Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium

https://doi.org/10.1016/0006-291X(90)90977-UGet rights and content

Abstract

Based on cDNA sequence data for human brain natriuretic peptide (BNP) precursor (1), a radioimmunoassay (RIA) system highly specific to human BNP (hBNP) was developed and used to characterize immunoreactive (ir-) hBNP in cardiac atrium. Gel filtration of ir-hBNP in atrium indicated that ir-hBNP was mainly comprised of two molecular forms of 13–15K and 4K. In reverse phase high performance liquid chromatography (HPLC), the low molecular weight (MW) ir-hBNP emerged as a single peak at an elution time identical to that of synthetic hBNP-32. The high MW ir-hBNP was also eluted as a single peak. On the other hand, tissue concentrations of ir-hBNP in cardiac atria were found to be 9.98–593.22 pmol/g in 13 specimens, being about 1/150 the concentration of ir-human atrial natriuretic peptide (hANP). These results demonstrate that hBNP is present as a peptide in human heart, suggesting that hBNP is secreted from heart and functions together with hANP as a hormone.

References (12)

  • SudohT. et al.

    Biochem. Biophys. Res. Commun.

    (1989)
  • MaekawaK. et al.

    Biochem. Biophys. Res. Commun.

    (1988)
  • KojimaM. et al.

    Biochem. Biophys. Res. Commun.

    (1989)
  • MatsuoH. et al.

    Endocrinol. Metab. Clin. North Am.

    (1987)
  • AburayaM. et al.

    Biochem. Biophys. Res. Commun.

    (1989)
  • KambayashiY. et al.

    Biochem. Biophys. Res. Commun.

    (1989)
There are more references available in the full text version of this article.

Cited by (0)

View full text